By Sahar Chmais  Kids 5 to 11 years old may soon be eligible for Pfizer’s COVID-19 vaccine after trials showed 'favorable safety' and a 'robust antibody response', according to Pfizer .  The trial for this age group had 2,268 participants who received a lower two-dose regimen than those ages 12 and ...